Login / Signup

Severe impairment of T-cell responses to BNT162b2 immunization in multiple myeloma patients.

Julius C EnssleJulia CampeAmelie SchwengerEliza WiercinskaHelen HellsternRalf DürrwaldMichael A RiegerSebastian WolfOlivier BalloBjörn SteffenHubert ServeHalvard BonigHolger F RabenauMarek WideraSandra CiesekIvana MetzlerEvelyn Ullrich
Published in: Blood (2021)
Keyphrases
  • end stage renal disease
  • multiple myeloma
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • early onset
  • drug induced